AbbVie Inc. (ABBV): Billionaire Ken Fisher Admires This Pharma Stock

robot
Abstract generation in progress

Billionaire Ken Fisher continues to hold and increase his stake in AbbVie Inc. (ABBV), a biopharmaceutical company, despite trimming it in 2020. Fisher’s admiration stems from his belief that political gridlock in the US limits sweeping drug-price regulation, thereby reducing long-term risk for pharmaceutical stocks. He increased his stake by 128% in the last quarter of 2025, now holding close to 630,000 shares.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin